{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:01:10Z","timestamp":1776988870251,"version":"3.51.4"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007059","name":"Univerzita Palack\u00e9ho v Olomouci","doi-asserted-by":"publisher","award":["JG_2019_002"],"award-info":[{"award-number":["JG_2019_002"]}],"id":[{"id":"10.13039\/501100007059","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ejmech.2020.113139","type":"journal-article","created":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T02:12:55Z","timestamp":1609207975000},"page":"113139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Small organic molecules targeting the energy metabolism of Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"212","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8249-028X","authenticated-orcid":false,"given":"Milan","family":"Urban","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8560-3916","authenticated-orcid":false,"given":"Veronika","family":"\u0160lachtov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8380-073X","authenticated-orcid":false,"given":"Lucie","family":"Brul\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.113139_bib1","series-title":"Global Tuberculosis Report 2019","author":"Organization","year":"2019"},{"key":"10.1016\/j.ejmech.2020.113139_bib2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.14745\/ccdr.v43i34a01","article-title":"Tuberculosis (TB): latent tuberculosis infection: an overview","volume":"43","author":"Kiazyk","year":"2017","journal-title":"Can. Comm. Dis. Rep."},{"key":"10.1016\/j.ejmech.2020.113139_bib3","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jac\/dkx506","article-title":"Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care","volume":"73","author":"Dookie","year":"2018","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2020.113139_bib4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/AAC.46.2.267-274.2002","article-title":"Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective","volume":"46","author":"Gillespie","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.113139_bib5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/antibiotics3030317","article-title":"Drug resistance mechanisms in Mycobacterium tuberculosis","volume":"3","author":"Palomino","year":"2014","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2020.113139_bib6","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/jac\/dkr173","article-title":"Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs","volume":"66","author":"Almeida Da Silva","year":"2011","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2020.113139_bib7","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1086\/420742","article-title":"Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases","volume":"38","author":"Peloquin","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.113139_bib8","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/jac\/dkh377","article-title":"Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?","volume":"54","author":"Di Perri","year":"2004","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2020.113139_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev.pa.19.040179.000413","article-title":"Toxicity of antibacterial agents: mechanism of action on mammalian cells","volume":"19","author":"Sanders","year":"1979","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2020.113139_bib10","first-page":"41","article-title":"Linezolid interaction with serotonin reuptake inhibitors: report of two cases and incidence assessment","volume":"25","author":"Go","year":"2010","journal-title":"Drug Metab. Pers. Ther."},{"key":"10.1016\/j.ejmech.2020.113139_bib11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200140050-00002","article-title":"Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials","volume":"40","author":"Burman","year":"2001","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2020.113139_bib12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.bjp.0703540","article-title":"Pharmacokinetics and metabolism of thioridazine during co-administration of tricyclic antidepressants","volume":"131","author":"Daniel","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.113139_bib13","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/femsre\/fux011","article-title":"Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives","volume":"41","author":"Gygli","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2020.113139_bib14","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1128\/AAC.02293-13","article-title":"Energy metabolism and drug efflux in Mycobacterium tuberculosis","volume":"58","author":"Black","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.113139_bib15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pbiomolbio.2019.11.006","article-title":"Unique structural and mechanistic properties of mycobacterial F-ATP synthases: implications for drug design","volume":"152","author":"Kamariah","year":"2020","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.ejmech.2020.113139_bib16","first-page":"1","article-title":"Targeting the menaquinol binding loop of mycobacterial cytochrome bd oxidase","author":"Harikishore","year":"2020","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2020.113139_bib17","doi-asserted-by":"crossref","first-page":"e00210","DOI":"10.1128\/JB.00210-19","article-title":"Insights into the physiology and metabolism of a mycobacterial cell in an energy-compromised state","volume":"201","author":"Patil","year":"2019","journal-title":"J.\u00a0Bacteriol."},{"key":"10.1016\/j.ejmech.2020.113139_bib18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.trsl.2020.03.007","article-title":"New tuberculosis drug targets, their inhibitors, and potential therapeutic impact","volume":"220","author":"Shetye","year":"2020","journal-title":"Transl. Res."},{"key":"10.1016\/j.ejmech.2020.113139_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.2010.01959.x","article-title":"Respiratory ATP synthesis: the new generation of mycobacterial drug targets?","volume":"308","author":"Bald","year":"2010","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.ejmech.2020.113139_bib20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nrmicro1065","article-title":"Tuberculosis: metabolism and respiration in the absence of growth","volume":"3","author":"Boshoff","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2020.113139_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2958.2009.06625.x","article-title":"Menaquinone synthesis is critical for maintaining mycobacterial viability during exponential growth and recovery from nonreplicating persistence","volume":"72","author":"Dhiman","year":"2009","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ejmech.2020.113139_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pbiomolbio.2019.11.003","article-title":"Two for the price of one: attacking the energetic-metabolic hub of mycobacteria to produce new chemotherapeutic agents","volume":"152","author":"Hards","year":"2020","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.ejmech.2020.113139_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbiomolbio.2020.02.001","article-title":"Targeting the cytochrome oxidases for drug development in mycobacteria","author":"Lee","year":"2020","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.ejmech.2020.113139_bib24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1128\/microbiolspec.MGM2-0015-2013","article-title":"Energetics of respiration and oxidative phosphorylation in mycobacteria","volume":"2","author":"Cook","year":"2014","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ejmech.2020.113139_bib25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/17460441.2020.1696771","article-title":"Emerging opportunities of exploiting mycobacterial electron transport chain pathway for drug-resistant tuberculosis drug discovery","volume":"15","author":"Roy","year":"2020","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2020.113139_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00272-17","article-title":"Targeting energy metabolism in Mycobacterium tuberculosis, a new paradigm in antimycobacterial drug discovery","volume":"8","author":"Bald","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.ejmech.2020.113139_bib27","series-title":"Molecular Biology of the Cell","author":"Alberts","year":"2004"},{"key":"10.1016\/j.ejmech.2020.113139_bib28","doi-asserted-by":"crossref","first-page":"15629","DOI":"10.1073\/pnas.0507850102","article-title":"Changes in energy metabolism of Mycobacterium tuberculosis in mouse lung and under in\u00a0vitro conditions affecting aerobic respiration","volume":"102","author":"Shi","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2020.113139_bib29","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/14728222.2017.1327577","article-title":"Type-II NADH Dehydrogenase (NDH-2): a promising therapeutic target for antitubercular and antibacterial drug discovery","volume":"21","author":"Sellamuthu","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejmech.2020.113139_bib30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF00762218","article-title":"Bacterial NADH-quinone oxidoreductases","volume":"23","author":"Yagi","year":"1991","journal-title":"J.\u00a0Bioenerg. Biomembr."},{"key":"10.1016\/j.ejmech.2020.113139_bib31","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1073\/pnas.0500469102","article-title":"Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs","volume":"102","author":"Weinstein","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2020.113139_bib32","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/MMBR.68.4.603-616.2004","article-title":"New insights into type II NAD(P)H:quinone oxidoreductases","volume":"68","author":"Melo","year":"2004","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.ejmech.2020.113139_bib33","doi-asserted-by":"crossref","first-page":"11945","DOI":"10.1073\/pnas.0711697105","article-title":"The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis","volume":"105","author":"Rao","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2020.113139_bib34","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1073\/pnas.1721545115","article-title":"Plasticity of Mycobacterium tuberculosis NADH dehydrogenases and their role in virulence","volume":"115","author":"Vilch\u00e8ze","year":"2018","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejmech.2020.113139_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008614","article-title":"Unique flexibility in energy metabolism allows mycobacteria to combat starvation and hypoxia","volume":"5","author":"Berney","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.ejmech.2020.113139_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002251","article-title":"High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism","volume":"7","author":"Griffin","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2020.113139_bib37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1371\/journal.ppat.1004510","article-title":"Succinate dehydrogenase is the regulator of respiration in Mycobacterium tuberculosis","volume":"10","author":"Hartman","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2020.113139_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002287","article-title":"Fumarate reductase activity maintains an energized membrane in anaerobic Mycobacterium tuberculosis","volume":"7","author":"Watanabe","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2020.113139_bib39","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1517\/13543784.2011.628657","article-title":"Phenothiazines as anti-tubercular agents: mechanistic insights and clinical implications","volume":"20","author":"Sharma","year":"2011","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejmech.2020.113139_bib40","doi-asserted-by":"crossref","first-page":"112420","DOI":"10.1016\/j.ejmech.2020.112420","article-title":"Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors","author":"Nizi","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113139_bib41","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1021\/ml300134b","article-title":"Quinolinyl pyrimidines: potent inhibitors of NDH-2 as a novel class of anti-TB agents","volume":"3","author":"Shirude","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.113139_bib42","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/j.bmcl.2018.05.048","article-title":"\u201cTethering\u201d fragment-based drug discovery to identify inhibitors of the essential respiratory membrane protein type II NADH dehydrogenase","volume":"28","author":"Heikal","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.113139_bib43","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1002\/anie.201800260","article-title":"Small molecules targeting Mycobacterium tuberculosis type II NADH dehydrogenase exhibit antimycobacterial activity","volume":"57","author":"Harbut","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2020.113139_bib44","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1021\/acsinfecdis.7b00275","article-title":"2-Mercapto-Quinazolinones as inhibitors of type II NADH dehydrogenase and Mycobacterium tuberculosis: structure-activity relationships, mechanism of action and absorption, distribution, metabolism, and excretion characterization","volume":"4","author":"Murugesan","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.113139_bib45","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.tube.2017.11.003","article-title":"The 7-phenyl benzoxaborole series is active against Mycobacterium tuberculosis","volume":"108","author":"Korkegian","year":"2018","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ejmech.2020.113139_bib46","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1016\/j.bmc.2010.03.021","article-title":"The anti-cancer, anti-inflammatory and tuberculostatic activities of a series of 6, 7-substituted-5, 8-quinolinequinones","volume":"18","author":"Mulchin","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113139_bib47","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1093\/jac\/dkw244","article-title":"Activation of type II NADH dehydrogenase by quinolinequinones mediates antitubercular cell death","volume":"71","author":"Heikal","year":"2016","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2020.113139_bib48","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1016\/j.bmc.2019.06.002","article-title":"The synthesis and evaluation of quinolinequinones as anti-mycobacterial agents","volume":"27","author":"Santoso","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113139_bib49","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.1128\/JB.187.18.6300-6308.2005","article-title":"Function of the cytochrome bc1-aa3 branch of the respiratory network in Mycobacteria and network adaptation occurring in response to its disruption","volume":"187","author":"Matsoso","year":"2005","journal-title":"J.\u00a0Bacteriol."},{"key":"10.1016\/j.ejmech.2020.113139_bib50","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00475-13","article-title":"Perturbation of cytochrome c maturation reveals adaptability of the respiratory chain in Mycobacterium tuberculosis","volume":"4","author":"Small","year":"2013","journal-title":"mBio"},{"key":"10.1016\/j.ejmech.2020.113139_bib51","doi-asserted-by":"crossref","first-page":"7076","DOI":"10.1128\/JB.183.24.7076-7086.2001","article-title":"Characterization of the cydAB-encoded cytochrome bd oxidase from Mycobacterium smegmatis","volume":"183","author":"Kana","year":"2001","journal-title":"J.\u00a0Bacteriol."},{"key":"10.1016\/j.ejmech.2020.113139_bib52","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1099\/mic.0.28723-0","article-title":"Evidence for a cytochrome bcc-aa3 interaction in the respiratory chain of Mycobacterium smegmatis","volume":"152","author":"Megehee","year":"2006","journal-title":"Microbiology"},{"key":"10.1016\/j.ejmech.2020.113139_bib53","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.bbabio.2012.11.008","article-title":"Structural analysis of cytochrome bc1 complexes: implications to the mechanism of function","volume":"1827","author":"Xia","year":"2013","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"10.1016\/j.ejmech.2020.113139_bib54","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0005-2728(87)90218-0","article-title":"Purification of highly active cytochrome bc1 complexes from phylogenetically diverse species by a single chromatographic procedure","volume":"891","author":"Ljungdahl","year":"1987","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"10.1016\/j.ejmech.2020.113139_bib55","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.1021\/bi00566a008","article-title":"Structural role of phospholipids in ubiquinol-cytochrome c reductase","volume":"19","author":"Yu","year":"1980","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2020.113139_bib56","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/bkcs.10765","article-title":"Putative 3D structure of QcrB from Mycobacterium tuberculosis cytochrome bc1 complex, a novel drug-target for new series of antituberculosis agent Q203","volume":"37","author":"Ko","year":"2016","journal-title":"Bull. Kor. Chem. Soc."},{"key":"10.1016\/j.ejmech.2020.113139_bib57","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1074\/jbc.H120.013113","article-title":"Self-control of vitamin K2 production captured in the crystal","volume":"295","author":"Blaise","year":"2020","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2020.113139_bib58","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1080\/07391102.2019.1688196","article-title":"Refined homology model of cytochrome bcc complex B subunit for virtual screening of potential anti-tuberculosis agents","volume":"38","author":"Pan","year":"2020","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2020.113139_bib59","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1128\/mr.54.2.101-129.1990","article-title":"Cytochrome bc1 complexes of microorganisms","volume":"54","author":"Trumpower","year":"1990","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2020.113139_bib60","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/24206","article-title":"Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. [Erratum to document cited in CA129:77224]","volume":"396","author":"Cole","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.113139_bib61","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00232-017-9997-3","article-title":"Mycobacterial membrane proteins QcrB and AtpE: roles in energetics, antibiotic targets, and associated mechanisms of resistance","volume":"251","author":"Bown","year":"2018","journal-title":"J.\u00a0Membr. Biol."},{"key":"10.1016\/j.ejmech.2020.113139_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.ampbs.2015.04.002","article-title":"The CydDC family of transporters and their roles in oxidase assembly and homeostasis","volume":"66","author":"Holyoake","year":"2015","journal-title":"Adv. Microb. Physiol."},{"key":"10.1016\/j.ejmech.2020.113139_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052951","article-title":"Identification of novel imidazo[1,2-a]pyridine inhibitors targeting M. tuberculosis QcrB","volume":"7","author":"Abrahams","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ejmech.2020.113139_bib64","doi-asserted-by":"crossref","first-page":"6962","DOI":"10.1128\/AAC.03486-14","article-title":"Respiratory flexibility in response to inhibition of cytochrome c oxidase in Mycobacterium tuberculosis","volume":"58","author":"Arora","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.113139_bib65","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1021\/id500008t","article-title":"Putting tuberculosis (TB) to rest: transformation of the sleep aid, Ambien, and \u201canagrams\u201d generated potent antituberculosis agents","volume":"1","author":"Moraski","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.113139_bib66","article-title":"Imidazopyridine compounds inhibit mycobacterial growth by depleting ATP levels","volume":"62","author":"O\u2019Malley","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.113139_bib67","doi-asserted-by":"crossref","first-page":"9371","DOI":"10.1021\/acs.jmedchem.5b01542","article-title":"Pyrrolo[3,4-c]pyridine-1,3(2H)-diones: a novel antimycobacterial class targeting mycobacterial respiration","volume":"58","author":"van der Westhuyzen","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113139_bib68","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1021\/acsinfecdis.7b00112","article-title":"Improved phenoxyalkylbenzimidazoles with activity against Mycobacterium tuberculosis appear to target QcrB","volume":"3","author":"Chandrasekera","year":"2017","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.113139_bib69","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1039\/C6MD00236F","article-title":"SAR and identification of 2-(quinolin-4-yloxy)acetamides as Mycobacterium tuberculosis cytochrome bc1 inhibitors","volume":"7","author":"Phummarin","year":"2016","journal-title":"Med. Chem. Comm."},{"key":"10.1016\/j.ejmech.2020.113139_bib70","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1021\/acsinfecdis.5b00154","article-title":"Arrival of imidazo[2,1-b]thiazole-5-carboxamides: potent anti-tuberculosis agents that target QcrB","volume":"2","author":"Moraski","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.113139_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227224","article-title":"Intracellular and in\u00a0vivo evaluation of imidazo [2, 1-b] thiazole-5-carboxamide anti-tuberculosis compounds","volume":"15","author":"Moraski","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.ejmech.2020.113139_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01677-17","article-title":"Combinations of respiratory chain inhibitors have enhanced bactericidal activity against Mycobacterium tuberculosis","volume":"62","author":"Berube","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.113139_bib73","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00606-19","article-title":"Identification of 4-Amino-Thieno[2,3-d]Pyrimidines as QcrB inhibitors in Mycobacterium tuberculosis","volume":"4","author":"Harrison","year":"2019","journal-title":"mSphere"},{"key":"10.1016\/j.ejmech.2020.113139_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008270","article-title":"New 2-ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis","volume":"16","author":"Lupien","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2020.113139_bib75","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijantimicag.2017.08.023","article-title":"Activity of 2-(quinolin-4-yloxy)acetamides in Mycobacterium tuberculosis clinical isolates and identification of their molecular target by whole-genome sequencing","volume":"51","author":"Subtil","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2020.113139_bib76","doi-asserted-by":"crossref","first-page":"6592","DOI":"10.1021\/acs.jmedchem.8b00172","article-title":"Identification of morpholino thiophenes as novel Mycobacterium tuberculosis inhibitors, targeting QcrB","volume":"61","author":"Cleghorn","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113139_bib77","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01276-18","article-title":"Arylvinylpiperazine amides, a new class of potent inhibitors targeting QcrB of Mycobacterium tuberculosis","volume":"9","author":"Foo","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.ejmech.2020.113139_bib78","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nm.3262","article-title":"Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis","volume":"19","author":"Pethe","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2020.113139_bib79","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1021\/acsinfecdis.8b00225","article-title":"Pyrazolo[1,5-a]pyridine inhibitor of the respiratory cytochrome bcc complex for the treatment of drug-resistant tuberculosis","volume":"5","author":"Lu","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.113139_bib80","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.bbabio.2014.01.022","article-title":"ATP synthase in mycobacteria: special features and implications for a function as drug target","volume":"1837","author":"Lu","year":"2014","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"10.1016\/j.ejmech.2020.113139_bib81","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-94-017-8742-0_15","article-title":"Respiration and oxidative phosphorylation in mycobacteria","volume":"39","author":"Berney","year":"2014","journal-title":"Adv. Photosynth. Respir."},{"key":"10.1016\/j.ejmech.2020.113139_bib82","doi-asserted-by":"crossref","first-page":"26441","DOI":"10.1074\/jbc.M113.503722","article-title":"Escherichia coli F1Fo-ATP synthase with a b\/\u03b4 fusion protein allows analysis of the function of the individual b subunits","volume":"288","author":"Gajadeera","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2020.113139_bib83","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jmb.2006.09.028","article-title":"ATP synthase b subunit dimerization domain: a right-handed coiled coil with offset helices","volume":"364","author":"Del Rizzo","year":"2006","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2020.113139_bib84","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1365-2958.2007.05857.x","article-title":"A\u00a0tridecameric c ring of the adenosine triphosphate (ATP) synthase from the thermoalkaliphilic Bacillus sp. strain TA2.A1 facilitates ATP synthesis at low electrochemical proton potential","volume":"65","author":"Meier","year":"2007","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ejmech.2020.113139_bib85","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.tibs.2006.12.001","article-title":"Integration of nutritional and stress signaling pathways by Maf1","volume":"32","author":"Willis","year":"2007","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejmech.2020.113139_bib86","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.1073\/pnas.081424898","article-title":"The preferred stoichiometry of c subunits in the rotary motor sector of Escherichia coli ATP synthase is 10","volume":"98","author":"Jiang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2020.113139_bib87","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0022-2836(87)90667-X","article-title":"The organization and sequence of the genes for ATP synthase subunits in the cyanobacterium Synechococcus 6301. Support for an endosymbiotic origin of chloroplasts","volume":"194","author":"Cozens","year":"1987","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2020.113139_bib88","doi-asserted-by":"crossref","first-page":"25273","DOI":"10.1074\/jbc.M803899200","article-title":"Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis","volume":"283","author":"Koul","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2020.113139_bib89","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1574-6968.2010.02123.x","article-title":"ATP synthase in slow- and fast-growing mycobacteria is active in ATP synthesis and blocked in ATP hydrolysis direction","volume":"313","author":"Haagsma","year":"2010","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.ejmech.2020.113139_bib90","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.bbabio.2014.01.022","article-title":"ATP synthase in mycobacteria: special features and implications for a function as drug target","volume":"1837","author":"Lu","year":"2014","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"10.1016\/j.ejmech.2020.113139_bib91","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nchembio884","article-title":"Diarylquinolines target subunit c of mycobacterial ATP synthase","volume":"3","author":"Koul","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2020.113139_bib92","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.1106753","article-title":"A\u00a0diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis","volume":"307","author":"Andries","year":"2005","journal-title":"Science (80)"},{"key":"10.1016\/j.ejmech.2020.113139_bib93","first-page":"112","article-title":"Bedaquiline\u2013The first ATP synthase inhibitor against multi drug resistant tuberculosis","volume":"5","author":"Lakshmanan","year":"2013","journal-title":"J.\u00a0Young Pharm."},{"key":"10.1016\/j.ejmech.2020.113139_bib94","doi-asserted-by":"crossref","first-page":"18831","DOI":"10.1039\/D0NJ02062A","article-title":"Gaining deeper insights into the surface binding of bedaquiline analogues with the ATP synthase subunit C of Mycobacterium tuberculosis using molecular docking, molecular dynamics simulation and 3D-QSAR techniques","volume":"44","author":"Lobo","year":"2020","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2020.113139_bib95","first-page":"1","article-title":"Structure of mycobacterial ATP synthase bound to the tuberculosis drug bedaquiline","author":"Guo","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.113139_bib96","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.bmc.2019.02.025","article-title":"Structure-activity relationships for unit C pyridyl analogues of the tuberculosis drug bedaquiline","volume":"27","author":"Blaser","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113139_bib97","first-page":"56","article-title":"Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium Tuberculosis","volume":"108","author":"Kumar","year":"2018","journal-title":"Tuberculosis (Oxford, United Kingdom)"},{"key":"10.1016\/j.ejmech.2020.113139_bib98","doi-asserted-by":"crossref","first-page":"904","DOI":"10.14233\/ajchem.2018.21145","article-title":"In silico Quest guided by physico-chemical descriptors of bedaquiline for new scaffolds with potential inhibitory capacity against homology model of mycobacterium F1F0 ATP synthase","volume":"30","author":"Munnaluri","year":"2018","journal-title":"Asian J. Chem."},{"key":"10.1016\/j.ejmech.2020.113139_bib99","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/cmdc.201600441","article-title":"Structural simplification of bedaquiline: the discovery of 3-(4-(N,N-Dimethylaminomethyl)phenyl)quinoline-Derived antitubercular lead compounds","volume":"12","author":"He","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2020.113139_bib100","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1021\/acs.jmedchem.6b01358","article-title":"Discovery of imidazo[1,2-a]pyridine ethers and squaramides as selective and potent inhibitors of mycobacterial adenosine triphosphate (ATP) synthesis","volume":"60","author":"Tantry","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113139_bib101","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1016\/j.bmcl.2017.05.081","article-title":"Identification and synthesis of novel inhibitors of mycobacterium ATP synthase","volume":"27","author":"Surase","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.113139_bib102","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2174\/1574885512666170911144732","article-title":"Preliminary studies on ligand-based design and evaluation of new mycobacterial ATP synthase inhibitors","volume":"13","author":"Sellamuthu","year":"2018","journal-title":"Curr. Drug Ther."},{"key":"10.1016\/j.ejmech.2020.113139_bib103","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1039\/C5MD00589B","article-title":"Scaffold morphing leading to evolution of 2,4-diaminoquinolines and aminopyrazolopyrimidines as inhibitors of the ATP synthesis pathway","volume":"7","author":"Tantry","year":"2016","journal-title":"Med. Chem. Comm."},{"key":"10.1016\/j.ejmech.2020.113139_bib104","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.bmc.2014.12.060","article-title":"Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis","volume":"23","author":"Singh","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113139_bib105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijantimicag.2012.09.012","article-title":"Biological evaluation of novel substituted chloroquinolines targeting mycobacterial ATP synthase","volume":"41","author":"Khan","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2020.113139_bib106","article-title":"Discovery of a novel Mycobacterial F-ATP synthase inhibitor and its potency in combination with diarylquinolines","author":"Hotra","year":"2020","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2020.113139_bib107","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1248\/bpb.34.1287","article-title":"Action-mechanism of trichoderin A, an anti-dormant mycobacterial aminolipopeptide from marine sponge-derived Trichoderma sp","volume":"34","author":"Pruksakorn","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2020.113139_bib108","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1021\/cb2004884","article-title":"A\u00a0high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosis","volume":"7","author":"Mak","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2020.113139_bib109","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms1060","article-title":"A\u00a0chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in\u00a0vivo efficacy","volume":"1","author":"Pethe","year":"2010","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2020.113139_bib110","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms1060","article-title":"A\u00a0chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in\u00a0vivo efficacy","volume":"1","author":"Pethe","year":"2010","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2020.113139_bib111","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1074\/jbc.RA118.005732","article-title":"Inhibitors of energy metabolism interfere with antibiotic-induced death in mycobacteria","volume":"294","author":"Lee","year":"2019","journal-title":"J.\u00a0Biol. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420311119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420311119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:21:19Z","timestamp":1759328479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420311119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":111,"alternative-id":["S0223523420311119"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.113139","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small organic molecules targeting the energy metabolism of Mycobacterium tuberculosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.113139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113139"}}